Single dose oral gabapentin for established acute postoperative pain in adults.
BACKGROUND
Gabapentin is an antiepileptic drug, also used in the treatment of neuropathic pain, which is the subject of a Cochrane review, currently under revision. Its efficacy in treating established acute postoperative pain has not been demonstrated.


OBJECTIVE
To assess the efficacy and safety of single dose oral gabapentin compared with placebo in established acute postoperative pain using methods that permit comparison with other analgesics.


METHODS
We searched Cochrane CENTRAL, MEDLINE, EMBASE, and the Oxford Pain Relief Database. Additional studies were sought from reference lists of retrieved articles and reviews. Clinical trials databases were searched for unpublished studies; clinical trial reports of several unpublished studies have been made public following litigation in the US.


METHODS
Single oral dose, randomised, double-blind, placebo-controlled trials of gabapentin for relief of established moderate to severe postoperative pain in adults.


METHODS
Studies were assessed for methodological quality and data extracted by two review authors independently. Numbers of participants with at least 50% of maximum possible total pain relief (TOTPAR) or summed pain intensity difference (SPID) with gabapentin or placebo were calculated and used to derive relative benefit (RB) or risk (RR), and number-needed-to-treat-to-benefit (NNT). Numbers of participants using rescue medication, and time to its use, were sought as additional measures of efficacy. Information on adverse events and withdrawals was collected.


RESULTS
Four unpublished studies met inclusion criteria; in three, participants had pain following dental surgery, and one followed major orthopaedic surgery; 177 participants were treated with a single dose of gabapentin 250 mg, 21 with gabapentin 500 mg, and 172 with placebo. At least 50% pain relief over 6 hours was achieved by 15% with gabapentin 250 mg and 5% with placebo; giving a RB of 2.5 (95% CI 1.2 to 5.0) and an NNT of 11 (6.4 to 35). Significantly fewer participants needed rescue medication within 6 hours with gabapentin 250 mg than with placebo; NNT to prevent use 5.8. About one third of participants reported adverse events with both gabapentin 250 mg and placebo. No serious adverse events occurred with gabapentin.


CONCLUSIONS
Gabapentin 250 mg is statistically superior to placebo in the treatment of established acute postoperative pain, but the NNT of 11 for at least 50% pain relief over 6 hours with gabapentin 250 mg is of limited clinical value and inferior to commonly used analgesics. Gabapentin 250 mg is not clinically useful as a stand-alone analgesic in established acute postoperative pain, though this is probably the first demonstration of analgesic effect of an antiepileptic in established acute pain.
Straube
Sebastian
S
Department of Occupational and Social Medicine, University of Göttingen, Waldweg 37 B, Göttingen, Germany, D-37073.
Derry
Sheena
S
Moore
R Andrew
RA
Wiffen
Philip J
PJ
McQuay
Henry J
HJ
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000588:Amines / Q000008:administration & dosage*; D000700:Analgesics / Q000008:administration & dosage*; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage*; D000077206:Gabapentin; D006801:Humans; D010149:Postoperative Pain / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage*
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin
Control Clin Trials. 1996 Feb;17(1):1-12
8721797
Br Med J (Clin Res Ed). 1988 May 7;296(6632):1313-6
3133061
Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007938
21412914
Postgrad Med J. 2005 Mar;81(953):155-60
15749790
Ann Intern Med. 1987 Aug;107(2):224-33
3300460
Cochrane Database Syst Rev. 2008;(4):
25267899
Br J Anaesth. 2007 Dec;99(6):775-86
18006529
Br J Anaesth. 2008 Jul;101(1):69-76
18503059
Anesth Analg. 2009 Jun;108(6):1945-9
19448227
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005452
16034978
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004233
18843655
Pain. 2001 Mar;91(1-2):189-94
11240091
Pain. 1997 Feb;69(3):311-315
9085306
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004768
19370609
Pain. 1997 Aug;72(1-2):95-7
9272792
Pain. 1996 Aug;66(2-3):229-37
8880845
Br Dent J. 2004 Oct 9;197(7):407-11; discussion 397
15475903
Drugs Today (Barc). 2008 May;44(5):353-68
18548137
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004309
19370600
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004602
18843665
Pain. 2005 Aug;116(3):322-331
15979792
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004234
19160232
BMJ. 1995 Feb 18;310(6977):452-4
7873954
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD001548
19588326
Pain. 1997 Jan;69(1-2):127-30
9060022
Pain. 1996 Aug;66(2-3):239-46
8880846
Anesth Analg. 2007 Jun;104(6):1545-56, table of contents
17513656
Pain. 1998 Dec;78(3):209-216
9870574